In the Hippo pathways, YAP and its paralog TAZ (transcriptional co-activator with PDZ-binding motif) are two critical oncogenic components acting through their interactions with transcriptional enhancer associate domain (TEAD1-4) family transcription factors and DNA binding partners to promote target genes involved in cancer progression [2–5]. This evidence concerns the gene WWTR1 and cancer.